SCHEMBL20736941

SCHEMBL20736941

c1ccc(-c2cccc(-c3cccc(-c4cc5c(c6ccccc46)-c4c(c6ccccc6c6ccccc46)C54c5ccccc5-c5ccccc54)c3)n2)nc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDK2 Q15119 1/20 0.40
CCR1 P32246 3/20 0.39
CCR5 P51681 3/20 0.39
CCR8 P51685 3/20 0.39
MAPK1 P28482 3/20 0.39
KDM4E B2RXH2 3/20 0.39
TP53 P04637 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
LMNA P02545 2/20 0.39
ALPL P05186 1/20 0.39
HSP90AA1 P07900 1/20 0.39
ALPI P09923 1/20 0.39
ALPG P10696 1/20 0.39
ALOX15 P16050 1/20 0.39
HTT P42858 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PRKDC P78527 1/20 0.34
HSD17B10 Q99714 2/20 0.32
NPC1 O15118 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20735778 0.92 PDK2 (0.40) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20735781 0.90 KDM4E (0.44) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20735811 0.89 PDK2 (0.40) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL27250393 0.88 PDK2 (0.37) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20736938 0.88 KDM4E (0.42) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20737069 0.87 PDK2 (0.38) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20737168 0.86 PDK2 (0.40) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20737283 0.86 PDK2 (0.39) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL20736957 0.85 PDK2 (0.43) PDK2CCR1CCR5CCR8MAPK1
SCHEMBL17862313 0.84 KDM4E (0.41) PDK2CCR1CCR5CCR8MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-12022728-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2024-06-25 US disclosed
US-11552251-B2 Organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2023-01-10 US disclosed
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2019-02-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11552251-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885CCR1 1730/4885CCR5 3344/4885
US-20190051835-A1 ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE L1CAM, ESR1, LEF1 PDK2 2420/4885CCR1 1730/4885CCR5 3344/4885
US-12022728-B2 Organic electroluminescent element and electronic device L1CAM, ESR1, LEF1 PDK2 2420/4885CCR1 1730/4885CCR5 3344/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.